| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
ARTICLES |
Department of Molecular & Cellular Pharmacology (J.M.G., L.S.L., K.L.B.), University of Miami School of Medicine, Miami, Florida 33101; Geriatric Research, Education and Clinical Center (K.L.B.), Miami VA Medical Center, Miami, Florida 33125; Department of Human Genetics (D.M.R.), University of Michigan School of Medicine, Ann Arbor, Michigan 48109
Address all correspondence and requests for reprints to: Kerry L. Burnstein, Ph.D., Department of Molecular & Cellular Pharmacology (R-189), P.O. Box 016189, Miami, Florida 33101. E-mail: kburnste{at}miami.edu
Androgen and glucocorticoid receptor (AR, GR), two closely related
members of the nuclear receptor superfamily, can recognize a similar
cis-acting DNA sequence, or hormone response element
(HRE). Despite this apparent commonality, these receptors regulate
distinct target genes in vivo. The AR gene itself is
regulated by AR but not GR in a variety of cell types, including
osteoblast-like cells, as shown here. To understand this specificity,
we first identified the DNA sequences responsible for androgen-mediated
up-regulation of AR messenger RNA. A 6.5-kb region encompassing exon D,
intron 4, and exon E of the AR gene contains four exonic HREs and
exhibits cell type-specific, AR-mediated transcriptional enhancement
when placed upstream of a heterologous promoter and reporter gene. A
350-bp fragment consisting of just exons D and E exhibits the same
cell- and androgen-specificity as the 6.5-kb region, as well as the
native AR gene. Consistent with a role for the exonic HREs, androgen
regulation via this intragenic enhancer requires the HREs as well as a
functional receptor DNA binding domain. A panel of AR/GR chimeric
receptors was used to test which AR domains (amino-terminal, DNA
binding or ligand binding) confer androgen-specific regulation of the
350-bp enhancer. Only chimeric receptors containing the amino-terminus
of AR induced reporter gene activity from the AR gene enhancer.
Further, a constitutively active AR consisting of only the AR
amino-terminus and DNA binding domain (AA
) retained the capacity to
activate the internal responsive region, unlike a constitutively active
chimera harboring the GR amino-terminus and AR DNA binding domain
(GA
). Thus, the AR amino terminus is the sole determinant for
androgen-specific regulation of the AR gene internal enhancer. These
findings support a model in which the amino termini of ARs bound to
HREs within the AR gene interact with an exclusive auxiliary factor(s)
to elicit androgen-specific regulation of AR messenger RNA. This is the
first example of androgen-specific response in which the necessary and
sufficient distinguishing capacity resides within the AR amino
terminus.
This article has been cited by other articles:
![]() |
X. Lampe, O. A. Samad, A. Guiguen, C. Matis, S. Remacle, J. J. Picard, F. M. Rijli, and R. Rezsohazy An ultraconserved Hox-Pbx responsive element resides in the coding sequence of Hoxa2 and is active in rhombomere 4 Nucleic Acids Res., June 1, 2008; 36(10): 3214 - 3225. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. P. Pelley, K. Chinnakannu, S. Murthy, F. M. Strickland, M. Menon, Q. P. Dou, E. R. Barrack, and G. P.-V. Reddy Calmodulin-Androgen Receptor (AR) Interaction: Calcium-Dependent, Calpain-Mediated Breakdown of AR in LNCaP Prostate Cancer Cells Cancer Res., December 15, 2006; 66(24): 11754 - 11762. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. Brodie and I. J McEwan Intra-domain communication between the N-terminal and DNA-binding domains of the androgen receptor: modulation of androgen response element DNA binding J. Mol. Endocrinol., June 1, 2005; 34(3): 603 - 615. [Abstract] [Full Text] [PDF] |
||||
![]() |
V. Wang, D. A. Davis, M. Haque, L. E. Huang, and R. Yarchoan Differential Gene Up-Regulation by Hypoxia-Inducible Factor-1{alpha} and Hypoxia-Inducible Factor-2{alpha} in HEK293T Cells Cancer Res., April 15, 2005; 65(8): 3299 - 3306. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. Kumar and E. B. Thompson Transactivation Functions of the N-Terminal Domains of Nuclear Hormone Receptors: Protein Folding and Coactivator Interactions Mol. Endocrinol., January 1, 2003; 17(1): 1 - 10. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Ohsako, Y. Miyabara, M. Sakaue, R. Ishimura, M. Kakeyama, H. Izumi, J. Yonemoto, and C. Tohyama Developmental Stage-Specific Effects of Perinatal 2,3,7,8-Tetrachlorodibenzo-p-dioxin Exposure on Reproductive Organs of Male Rat Offspring Toxicol. Sci., April 1, 2002; 66(2): 283 - 292. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Endocrinology | Endocrine Reviews | J. Clin. End. & Metab. |
| Molecular Endocrinology | Recent Prog. Horm. Res. | All Endocrine Journals |